Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Penn Doctors Certified in New Advanced Heart Failure and Transplant Cardiology Specialty

February 18, 2011 6:33 am | by University Of Pennsylvania | News | Comments

Penn Medicine cardiologists are leaders in a new cardiology subspecialty, Advanced Heart Failure and Transplant Cardiology. Seven of the nine Heart Failure and Transplant doctors at Penn are now certified by the American Board of Internal Medicine (ABIM) in the new Advanced Heart Failure...

Boston Scientific Launches PROMUS® Elementâ„¢ and TAXUS® Elementâ„¢ Stent Systems in India

February 18, 2011 3:36 am | by Boston Scientific | News | Comments

Company's third-generation drug-eluting stents now available in rapidly growing market

MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors

February 18, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Feb. 18, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced the appointment of Scott R. Ward as Chairman of its Board of Directors. Steven A. Elms, the incumbent Chairman and an original venture capital investor in the Company, will step down from the...

Advertisement

Fujifilm's Synapse® Mobility Extends Imaging Reach

February 18, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., Feb. 18, 2011 /- FUJIFILM Medical Systems U.S.A., Inc. will be showcasing Synapse® Mobility*, its zero footprint mobile application enabling remote access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based...

FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor

February 17, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm...

New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%

February 17, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Tenn., Feb. 17, 2011 /- Georgia Health Sciences University, Augusta, GA  exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies ' zero displacement InVision-Plus® IV...

Announcement - Clontech Laboratories, Inc. Releases the Tet-Expressâ„¢ Inducible Expression System

February 17, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Feb. 17, 2011 /- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the release of the Tet-Express Inducible Expression System , which provides the quickest and simplest Tet-inducible expression technology yet. At the heart of...

New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review

February 16, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M., Feb. 16, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the company will begin providing second opinion...

Advertisement

CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia

February 16, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

KING OF PRUSSIA, Pa. and MONTREAL, Feb. 16, 2011 /- As a means of aiding the World Federation of Hemophilia's (WFH) progress in improving the diagnosis and treatment of hemophilia in developing countries through its Global Alliance for Progress (GAP) program, CSL Behring has committed to...

Patient-Derived Heart Cells Mimic Disease

February 15, 2011 4:34 am | by Massachusetts Institute of Technology | News | Comments

The cells point to new potential therapies for an inherited heart defect.

Governor Corbett Announces at Least 80 New Jobs in Lehigh Valley with Pharmaceutical Company's Purchase, Renovation of Former Amcor Site

February 15, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Governor Tom Corbett today announced that the global pharmaceutical company Daiichi Sankyo Inc. will create more than 80 jobs in the Lehigh Valley with the establishment of its first U.S. manufacturing and packaging operation....

Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer

February 15, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

SAN JOSE, Calif., Feb. 15, 2011 /- Baxano, Inc. ( w w w.b a x a no. c om ) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources. Mr. Harter...

Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine

February 15, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Feb. 15, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that it has established a $1.7 million endowment to fund the "Donald S. Baim, M.D., '75 Scholarship Fund" for Yale School of Medicine.  This scholarship fund will honor the late interventional...

Advertisement

Nfocus Neuromedical, Inc. Lunaâ„¢ Aneurysm Embolization System Receives CE Mark

February 15, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Feb. 15, 2011 /- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna™ Aneurysm Embolization System (AES) received CE Mark for the treatment of patients...

Covidien to Launch TurboHawk(TM) Plaque Excision System for Small Vessels

February 15, 2011 2:33 am | by Covidien | News | Comments

New system offers greater efficiency and more consistent performance for physicians MANSFIELD, Mass., Feb 15, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it will launch the TurboHawk(TM) Plaque Excision System for...

New Anti-Clotting Drug Added to Recommendations for Treating Irregular Heartbeat

February 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

DALLAS, Feb. 14, 2011 /PRNewswire-USNewswire/ -- The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association...

ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination

February 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Feb. 14, 2011 /- Zoledronic acid (sold by Novartis as Zometa, Aclasta, and Reclast) is used to treat Osteoporosis, Tumor Metastasis, and Paget's Disease with sales of $2 billion a year.(1)  It is associated with side effects such as post-dose syndrome and osteonecrosis of...

Dynatronics Announces Fiscal Second Quarter Results

February 14, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Feb. 14, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced results for its fiscal second quarter ended December 31, 2010. Sales for the quarter ended December 31, 2010, were $8,199,347, compared to $8,501,437 for the quarter ended December 31, 2009. Sales for...

ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.

February 14, 2011 12:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 14, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has entered into a definitive agreement to acquire SynthRx, Inc. (SynthRx), a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer...

Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Re...

February 11, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Feb. 11, 2011 /- Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were...

Kips Bay Medical, Inc. Announces Pricing of its Initial Public Offering of Common Stock

February 11, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Feb. 10, 2011 /- Kips Bay Medical, Inc. (Nasdaq: KIPS ) announced today the pricing of the Company's initial public offering of 2,062,500 shares of its common stock at a price of $8.00 per share.  The shares are expected to begin trading on February 11, 2011 on the...

PerkinElmer's Friel pulls in $3M in restricted stock

February 11, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

PerkinElmer Inc. CEO Robert Friel this week received restricted stock worth nearly $3 million and the option to buy about 200,000 shares.

Lilly Announces Senior Leadership Changes

February 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Feb. 11, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that Sue Mahony, currently senior vice president of human resources and diversity, has been named senior vice president and president of Lilly Oncology. In this new role she continues to report to John...

Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer

February 9, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

GLEN ALLEN, Va., Feb. 9, 2011 /- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (Nasdaq: CIGX ) announced that on February 4 a provisional patent application was filed with the Patent and Trademark Office ("PTO") for administering a pure form of a single isomer of...

Americord Becomes Only Family Cord Blood Bank Headquartered in New York City to Hold State Cord Blood License

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 9, 2011 /- Americord Registry , a pioneer in cord blood and placenta stem cell preservation, is proud to announce that it has obtained a provisional human tissue cord blood banking license from the New York State Department of Health, becoming the first private umbilical...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading